PGY2 Thrombosis and Hemostasis Management Residency
Johns Hopkins Hospital is an 1194-bed academic medical center and level 1 trauma center in Baltimore, MD. We established our novel anticoagulation and hemostatic stewardship program in 2017 and are national leaders in this growing area of practice. The Department of Pharmacy, consistent with the mission of Johns Hopkins Medicine, places a priority on patient care, teaching and research.
The Thrombosis and Hemostasis PGY2 residency program is designed to provide advanced training in clinical pharmacy practice, research, and education focusing on of patients with thrombotic and hemostatic disorders. Learning experiences include but are not limited to benign hematology, anticoagulation stewardship, cardiovascular intensive care units (medical and surgical), general cardiology, ambulatory anticoagulation management (adult and pediatrics), and medication safety. Dedicated research time will be provided.
The resident will join a group of > 30 residents and will participate in an in-house on call program. There is a large pharmacy student presence in the department and the thrombosis and hemostasis will be actively involved in a both didactic and experiential teaching. The resident will provide ACPE accredited lectures, in addition to less formal presentations and topic discussions. An elective teaching certificate is available. Full support to attend professional meetings, including ASHP MCM and one other professional conference, is provided. Staffing responsibilities are roughly one weekend out of three in the Adult Medicine, Emergency, and Surgery satellite pharmacy. When covering on-call duties on the weekend, the resident is relieved from satellite staffing.
Kathryn Dane, Pharm.D., BCPS
Clinical Pharmacy Specialist, Benign Hematology and Cardiology
Co-Director, Hemostatic and Antithrombotic Stewardship Program
PGY-2 Thrombosis and Hemostasis Management Residency Program Director
From the 1889 opening of The Johns Hopkins Hospital, to the opening of the School of Medicine four years later, there emerged the concept of combining research, teaching and patient care. This model, the first of its kind, would lead to a national and international reputation for excellence and discovery.Today, Johns Hopkins uses one overarching name—Johns Hopkins Medicine—to identify its entire medical enterprise. This $6.7 billion system unites the physicians and scientists of the Johns Hopkins University School of Medicine with the health professionals and facilities that make up the broad, integrated Johns Hopkins Health System.